EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression

Min Hee Kim, Eun-Ji Lee, Su-Jeong Kim, Yun-Jae Jung, Woo-Jae Park iD, Inkeun Park

PLOS ONE · 13.06.2023 · 18 (6) · e0287146

DOI: 10.1371/journal.pone.0287146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.06.2023. Verfasst von Min Hee Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Gallstones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage inhibitory cytokine 1 (MIC-1), which is overproduced in various human cancers and associated with cachexia, acts on the hypothalamus to suppress appetite and reduce body weight. We investigated the mechanisms through which MIC-1 affects bile acid metabolism and gallstone formation, which are poorly understood. Over 6 weeks, male C57BL/6 mice fed either standard chow or a lithogenic diet were intraperitoneally injected with phosphate-buffered saline (PBS) or MIC-1 (200 μg/kg/week). Among lithogenic diet–fed mice, MIC-1 treatment resulted in increased gallstone formation compared with PBS treatment. Compared with PBS treatment, MIC-1 treatment decreased hepatic cholesterol and bile acid levels and reduced expression of HMG-CoA reductase (HMGCR), the master cholesterol metabolism regulator sterol regulatory element-binding protein 2, cholesterol 7α-hydroxylase (CYP7A1), mitochondrial sterol 27-hydroxylase, and oxysterol 7α-hydroxylase. Compared with PBS treatment, MIC-1 treatment had no effect on small heterodimer partner, farnesoid X receptor, or pregnane X receptor expression, and extracellular signal–related kinase and c-Jun N-terminal kinase phosphorylation decreased, suggesting that these factors do not contribute to the MIC-1–induced reduction in CYP7A1 expression. Compared with PBS treatment, MIC-1 treatment increased AMP-activated protein kinase (AMPK) phosphorylation. Treatment with the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reduced CYP7A1 and HMGCR expression, whereas the AMPK inhibitor Compound C reversed MIC-1-induced reductions in CYP7A1 and HMGCR expression. Furthermore, in MIC-1-treated mice, total biliary cholesterol levels increased together with increased ATP-binding cassette subfamily G (ABCG)5 and ABCG8 expression. Compared with PBS treatment, MIC-1 treatment did not affect expression of liver X receptors α and β, liver receptor homolog 1, hepatocyte nuclear factor 4α, or NR1I3 (also known as constitutive androstane receptor), which are upstream of ABCG5/8; however, MIC-1 treatment increased ABCG5/8 expression and promoter activities. Our study indicates that MIC-1 influences gallstone formation by increasing AMPK phosphorylation, reducing CYP7A1 and HMGCR expression, and increasing ABCG5 and ABCG8 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GallstonesHumansMaleAnimalsMiceMice, Inbred C57BLGrowth Differentiation Factor 15AMP-Activated Protein KinasesDietMacrophagesATP Binding Cassette Transporter, Subfamily G, Member 8ATP Binding Cassette Transporter, Subfamily G, Member 5Lipoproteins

Substanzen

Growth Differentiation Factor 15AMP-Activated Protein KinasesABCG8 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 8ABCG5 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 5LipoproteinsABCG5 protein, mouseABCG8 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Biochemistry, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
  • Department of Microbiology, Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University, Incheon, Republic of Korea.
  • Department of Health Science and Technology, Gachon Advanced Institute for Health Science & Technology, Gachon University, Incheon, Republic of Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Woo-Jae Park

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, M. H., Lee, E. J., Kim, S. J., Jung, Y. J., Park, W. J., & Park, I. (2023). Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression. PLOS ONE, 18(6), e0287146. https://doi.org/10.1371/journal.pone.0287146

Vancouver

Kim MH, Lee EJ, Kim SJ, Jung YJ, Park WJ, Park I. Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression. PLOS ONE. 2023;18(6):e0287146. doi:10.1371/journal.pone.0287146

BibTeX
@article{Kim2023,
  author = {Kim, Min Hee and Lee, Eun-Ji and Kim, Su-Jeong and Jung, Yun-Jae and Park, Woo-Jae and Park, Inkeun},
  title = {Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {e0287146},
  doi = {10.1371/journal.pone.0287146}
}
Kostenlos starten →